Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

All Approvals and Tentative Approvals
February 1960

This report includes approvals of NDAs, BLAs, ANDAs, and approved supplements to those applications, and tentative ANDA/NDA approvals during the selected month. This report does not include BLAs/NDAs and supplements to those applications approved by CBER.

Click on the Drug Name and Application Number to see information about the drug (for example, regulatory history, labeling, reviews by FDA staff).

This report was produced on October 19, 2020.

Approval Date Drug Name Submission Active Ingredients Company Submission Classification * Submission Status
02/11/1960 SER-AP-ES
NDA #012193
ORIG-1 HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE NOVARTIS Type 4 - New Combination Approval
02/15/1960 DECLOMYCIN
NDA #050262
SUPPL-21 DEMECLOCYCLINE HYDROCHLORIDE LEDERLE Labeling Approval
02/23/1960 MYDRIACYL
NDA #012111
ORIG-1 TROPICAMIDE ALCON Type 1 - New Molecular Entity Approval
02/24/1960 LIBRIUM
NDA #012249
ORIG-1 CHLORDIAZEPOXIDE HYDROCHLORIDE VALEANT PHARM INTL Type 1 - New Molecular Entity Approval

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English